PhaseBio Pharmaceuticals logo
PhaseBio Pharmaceuticals PHAS
$ 0.13 7.4%

Quarterly report 2022-Q2
added 08-12-2022

report update icon

PhaseBio Pharmaceuticals EV/EBITDA Ratio 2011-2024 | PHAS

Annual EV/EBITDA Ratio PhaseBio Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.89 -1.15 -1.88 1.78 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.78 -1.89 -0.786